Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Transfusion ; 64(4): 615-626, 2024 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-38400625

RESUMEN

BACKGROUND: Donor genetic variation is associated with red blood cell (RBC) storage integrity and post-transfusion recovery. Our previous large-scale genome-wide association study demonstrated that the African G6PD deficient A- variant (rs1050828, Val68Met) is associated with higher oxidative hemolysis after cold storage. Despite a high prevalence of X-linked G6PD mutation in African American population (>10%), blood donors are not routinely screened for G6PD status and its importance in transfusion medicine is relatively understudied. STUDY DESIGN AND METHODS: To further evaluate the functional effects of the G6PD A- mutation, we created a novel mouse model carrying this genetic variant using CRISPR-Cas9. We hypothesize that this humanized G6PD A- variant is associated with reduced G6PD activity with a consequent effect on RBC hemolytic propensity and post-transfusion recovery. RESULTS: G6PD A- RBCs had reduced G6PD protein with ~5% residual enzymatic activity. Significantly increased in vitro hemolysis induced by oxidative stressors was observed in fresh and stored G6PD A- RBCs, along with a lower GSH:GSSG ratio. However, no differences were observed in storage hemolysis, osmotic fragility, mechanical fragility, reticulocytes, and post-transfusion recovery. Interestingly, a 14% reduction of 24-h survival following irradiation was observed in G6PD A- RBCs compared to WT RBCs. Metabolomic assessment of stored G6PD A- RBCs revealed an impaired pentose phosphate pathway (PPP) with increased glycolytic flux, decreasing cellular antioxidant capacity. DISCUSSION: This novel mouse model of the common G6PD A- variant has impaired antioxidant capacity like humans and low G6PD activity may reduce survival of transfused RBCs when irradiation is performed.


Asunto(s)
Deficiencia de Glucosafosfato Deshidrogenasa , Glucosafosfato Deshidrogenasa , Humanos , Ratones , Animales , Glucosafosfato Deshidrogenasa/genética , Glucosafosfato Deshidrogenasa/metabolismo , Hemólisis , Deficiencia de Glucosafosfato Deshidrogenasa/genética , Deficiencia de Glucosafosfato Deshidrogenasa/epidemiología , Antioxidantes , Estudio de Asociación del Genoma Completo , Eritrocitos/metabolismo , Donantes de Sangre
2.
Artículo en Inglés | MEDLINE | ID: mdl-38901043

RESUMEN

Postmenopausal cardiovascular health is a critical determinant of longevity. Consumption of beetroot juice (BR) and other nitrate rich foods is a safe, effective non-pharmacological intervention strategy to increase systemic bioavailability of the vasoprotective molecule, nitric oxide (NO), through the exogenous nitrate (NO3-)-nitrite (NO2-)-NO pathway. We hypothesized that a single dose of nitrate-rich beetroot juice (BRnitrate 600 mg NO3- / 140 mL, BRplacebo ~ 0 mg/ 140 mL) would improve resting endothelial function and resistance to ischemia-reperfusion (IR) injury to a greater extent in early- (1-6 years following their final menstrual period (FMP), n=12) compared to late- (6+ years after FMP, n=12) postmenopausal women. Analyses with general linear models revealed a significant (p<0.05) time*treatment interaction effect for brachial artery adjusted FMD. Pairwise comparisons revealed adjusted FMD was significantly lower following IR-injury in comparison to all other time points with BRplacebo (Early FMD 2.51 ± 1.18%, Late FMD 1.30 ± 1.10, p<0.001) and was lower than post-IR with BRnitrate (Early FMD 3.84 ± 1.21%, Late FMD 3.21 ± 1.13 %, p=0.014). Considering the postmenopausal stage-dependent variations in endothelial responsiveness to dietary nitrate at rest and post-IR, we predict differing mechanisms underpin macrovascular protection against IR injury. NCT03644472.

3.
Biophys J ; 2024 Aug 21.
Artículo en Inglés | MEDLINE | ID: mdl-39175196
4.
Front Nutr ; 11: 1359671, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38915856

RESUMEN

Introduction: Cardiovascular disease (CVD) is the leading cause of death in women, with increased risk following menopause. Dietary intake of beetroot juice and other plant-based nitrate-rich foods is a promising non-pharmacological strategy for increasing systemic nitric oxide and improving endothelial function in elderly populations. The purpose of this randomized, placebo-controlled, double-blind, crossover clinical trial was to determine the effects of short-term dietary nitrate (NO3 -) supplementation, in the form of beetroot juice, on resting macrovascular endothelial function and endothelial resistance to whole-arm ischemia-reperfusion (IR) injury in postmenopausal women at two distinct stages of menopause. Methods: Early-postmenopausal [1-6 years following their final menstrual period (FMP), n = 12] and late-postmenopausal (6+ years FMP, n = 12) women consumed nitrate-rich (400 mg NO3 -/70 mL) and nitrate-depleted beetroot juice (approximately 40 mg NO3 -/70 mL, placebo) daily for 7 days. Brachial artery flow-mediated dilation (FMD) was measured pre-supplementation (Day 0), and approximately 24 h after the last beetroot juice (BR) dose (Day 8, post-7-day BR). Consequently, FMD was measured immediately post-IR injury and 15 min later (recovery). Results: Results of the linear mixed-effects model revealed a significantly greater increase in resting FMD with 7 days of BRnitrate compared to BRplacebo (mean difference of 2.21, 95% CI [0.082, 4.34], p = 0.042); however, neither treatment blunted the decline in post-IR injury FMD in either postmenopausal group. Our results suggest that 7-day BRnitrate-mediated endothelial protection is lost within the 24-h period following the final dose of BRnitrate. Conclusion: Our findings demonstrate that nitrate-mediated postmenopausal endothelial protection is dependent on the timing of supplementation in relation to IR injury and chronobiological variations in dietary nitrate metabolism. Clinical trial registration: https://classic.clinicaltrials.gov/ct2/show/NCT03644472.

5.
Blood Adv ; 8(10): 2552-2564, 2024 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-38537079

RESUMEN

ABSTRACT: Malaria is a highly oxidative parasitic disease in which anemia is the most common clinical symptom. A major contributor to the malarial anemia pathogenesis is the destruction of bystander, uninfected red blood cells (RBCs). Metabolic fluctuations are known to occur in the plasma of individuals with acute malaria, emphasizing the role of metabolic changes in disease progression and severity. Here, we report conditioned medium from Plasmodium falciparum culture induces oxidative stress in uninfected, catalase-depleted RBCs. As cell-permeable precursors to glutathione, we demonstrate the benefit of pre-exposure to exogenous glutamine, cysteine, and glycine amino acids for RBCs. Importantly, this pretreatment intrinsically prepares RBCs to mitigate oxidative stress.


Asunto(s)
Aminoácidos , Eritrocitos , Estrés Oxidativo , Plasmodium falciparum , Plasmodium falciparum/efectos de los fármacos , Eritrocitos/parasitología , Eritrocitos/metabolismo , Eritrocitos/efectos de los fármacos , Humanos , Estrés Oxidativo/efectos de los fármacos , Aminoácidos/metabolismo , Malaria Falciparum/prevención & control , Malaria Falciparum/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA